Onyee Chan
Hematologist-oncologist focused on CML management with experience in TKI toxicities, dose optimization, and patient counseling in clinical practice.
Best podcasts with Onyee Chan
Ranked by the Snipd community
Nov 10, 2025 • 22min
Managing Toxicities of Tyrosine Kinase Inhibitors (TKI) in CML - Drs. Onyee Chan & Fadi Haddad
This discussion features Dr. Fadi Haddad, a hematologist-oncologist specializing in chronic myeloid leukemia (CML) and TKI management, alongside Dr. Onyee Chan, an expert in CML toxicities and patient counseling. They explore the various generations of tyrosine kinase inhibitors and their class-wide toxicities. Key topics include unique side effects of each TKI, strategies for dose optimization, and the critical role of patient education in managing complications effectively. They also delve into specific drug issues, including dasatinib monitoring and bosutinib's GI side effects.
Dec 23, 2024 • 14min
S11 Ep45: Asciminib and Ponatinib Sit at the Forefront of Advances in CML Management: Insights From Onyee Chan, MD; and Bradley D. Hunter, MD
Join Dr. Onyee Chan, a hematologist-oncologist specializing in myeloid malignancies, and Dr. Bradley D. Hunter, a physician-scientist and medical director, as they dive into the latest advancements in chronic myeloid leukemia (CML) management. They emphasize the importance of integrating asciminib as a first-line therapy and discuss optimal treatment sequencing. Key insights include the impact of the OPTIC trial on ponatinib dosing strategies and the role of mutational testing in personalizing patient care. The dialogue also explores the evolving relevance of stem cell transplantation in treatment.
